Definitive Contract W911SR22C0032
Award Date
5/12/22
Potential Completion Date
9/24/22
Potential Value
$7.5M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Siga Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10065, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive firm fixed-price contract awarded by the Joint PEO Chemical and Biological Defense agency, a subcomponent of the U.S. Department of Defense, to Siga Technologies, Inc. The $8,999,677.03 contract is for the procurement of 23,030 oral courses and 50 intravenous courses of TPOXX, an FDA-approved therapeutic medication used for treating smallpox and related viral infections. The contract has a completion date of December 31, 2024 and does not utilize any small business set-aside...
This is a $748,857,151.46 firm fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer, to develop and deliver the ACAM2000 smallpox (vaccinia) vaccine over a 10-year period. The contract was awarded on a sole-source basis as Emergent is the only FDA-licensed provider of ACAM2000. This contract does not have a set-aside...
This is a $12,549,999,847.50 Definitive Contract awarded by the U.S. Army Contracting Command - Aberdeen Proving Ground, Natick Division on behalf of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Biomedical Advanced Research and Development Authority (BARDA) to Pfizer Inc. for the delivery of 10 million treatment courses of the oral protease inhibitor PF-07321332. This contract, which does not utilize a small business...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Roche Laboratories Inc. for the purchase of Tamiflu® (antiviral medication) for the Strategic National Stockpile. The contract is a definitive contract with a firm fixed price of $199,048,013.60 and does not have a set-aside designation. The contract was awarded on September 30, 2009 with a period of performance ending on September 29, 2011. Roche Laboratories Inc....
This is a $1,417.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of oseltamivir phosphate 75 mg capsules, which are used to treat influenza. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $1,853.16 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Oseltamivir Phosphate 75 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
<p>The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a Definitive Contract valued at $7,837,399,999.00 to Moderna US, Inc. Moderna US Inc. Division for COVID-19 MRNA Vaccines. The place of performance will be in Cambridge, MA 02139, USA and the period of performance is from July 28, 2022 through March 31, 2023. The pricing structure is Firm Fixed Price.</p>
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $16.5 million Other Transaction Agreement to Rigel Pharmaceuticals Inc. to support the development of a therapeutic to treat COVID-19. The prototype effort will take place in South San Francisco, California through May 2023. No set-aside designation was applied to this award made under the "COVID-19" PROTOTYPE DEVELOPMENT OF A THEREAPUTIC TO TREAT COVID-19 solicitation. As the...
<p>This is a $323,554,976.00 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Paratek Pharmaceuticals, Inc. for the development of an antibiotic to treat a biothreat indication. The contract has an ultimate completion date of December 17, 2029 and was awarded on December 18, 2019. This contract is not associated with a set-aside program.</p>
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the U.S. government. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a combat support agency of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medical products and supplies to federal agencies, particularly the DoD and Department of Veterans...